General Practice Doctors in Cherry Hill, NJ Accepting Medicare

4 General Practice doctors found. Showing 1 - 4

Dr. Joyce Goldsmith, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 205 Henfield Ave, Cherry Hill, NJ 08003 Phone: 856-266-1201

Dr. Beverly Haines Truxton, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 200 Sawmill Rd, Cherry Hill, NJ 08034 Phone: 856-857-0468

Dr. Alan Stein, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1604 Crown Point Ln, Cherry Hill, NJ 08003 Phone: 856-795-0573

Dr. Bruce Taubman, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 600 Marlton Pike W, Cherry Hill, NJ 08002 Phone: 856-428-5020    Fax: 856-216-9433

News Archive

3D-printed adaptive aids can benefit patients with arthritis

Adaptive aids are expensive. Additive manufacturing, using low-cost 3D printers, can save upwards of 94 percent for simple household items.

arGEN-X collaborates with Bayer Pharma for development of therapeutic antibodies

arGEN-X, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, announced today the initiation of a collaboration with Bayer Pharma AG (Bayer), leveraging arGEN-X's SIMPLE Antibody™ technology for the discovery and development of therapeutic antibodies.

Low dose aspirin dosages trigger the body to generate its own anti-inflammatory compounds

Researchers at Brigham and Women's Hospital (BWH) and colleagues have demonstrated for the first time in humans in a randomized clinical trial that low-dose aspirin - dosages equivalent to one baby aspirin (81 mg) - trigger the body to generate its own anti-inflammatory compounds that help fight unwanted inflammation.

Gleevec available to patients in post-surgical GIST study

Investigators will begin offering Gleevec(R) (imatinib mesylate)* tablets to patients receiving placebo in a major North American clinical trial after an interim analysis showed participants with Kit-positive gastrointestinal stromal tumors treated with Gleevec following surgery were significantly less likely to experience a return of their cancer compared to those not taking this innovative therapy.

Read more Medical News

› Verified 1 days ago